What was the total gross revenue for Dermani Medspa's Company Location 4, which opened in September 2015?
Dermani_Medspa Franchise · 2025 FDDAnswer from 2025 FDD Document
| Company Location 1 | Company Location 2 | Company Location 3 | Company Location 4 | Company Location 5 | |
|---|---|---|---|---|---|
| (Opened Since) | (Sept 2013) | (April 2014) | (April 2014) | (Sept 2015) | (April 2017) |
| Gross Revenue1 | |||||
| Retail Product Sales | $49,493 | $68,241 | $57,796 | $92,653 | $75,542 |
| Services Revenue | $1,269,346 | $1,821,457 | $1,084,216 | $2,224,396 | $1,861,911 |
| Total Gross Revenue | $1,318,839 | $1,889,698 | $1,142,012 | $2,317,049 | $1,937,453 |
| Disclosed Expenses2 | |||||
| Cost of Goods Sold3 | $513,850 | $650,076 | $371,760 | $897,103 | $635,977 |
| Payroll Expenses4 | $488,274 | $628,474 | $469,474 | $789,900 | $711,427 |
| Rent Expense5 | $124,780 | $126,075 | $67,962 | $56,886 | $101,877 |
| Spa Supplies6 | $102,929 | $131,171 | $107,920 | $137,642 | $158,280 |
Source: Item 19 — FINANCIAL PERFORMANCE REPRESENTATIONS (FDD pages 58–61)
What This Means (2025 FDD)
According to Dermani Medspa's 2025 Franchise Disclosure Document, Company Location 4, which opened in September 2015, had a total gross revenue of $2,317,049 during the measurement period of January 1, 2024, to December 31, 2024. This revenue is comprised of $92,653 in retail product sales and $2,224,396 in service revenue. This data reflects the financial performance of one of Dermani Medspa's company-owned locations during that specific 12-month period.
It is important to note that this financial performance data is based on unaudited information reported to Dermani Medspa by its affiliates. The FDD explicitly states that no certified public accountant has audited these figures or expressed an opinion on their accuracy. Dermani Medspa also clarifies that individual results may vary, and there is no guarantee that a franchisee will achieve similar revenue figures.
Prospective franchisees should carefully review all the information in Item 19 of the FDD, including the notes and disclaimers, in conjunction with their own due diligence and financial projections. Dermani Medspa makes written substantiation of all financial performance information available at their main office upon reasonable request. If a prospective franchisee receives any financial performance information or projections outside of Item 19, they are advised to report it to Dermani Medspa's management, the Federal Trade Commission, and the appropriate state regulatory agencies.